Biogen Pharmachem Industries Ltd
Ticker: BIOGEN
Decent
54/100
☆ Add to Watchlist
Investing Reference
Price
0.86
Market Cap
77.62
Debt/Equity
0.0000
ROE %
-0.391
PB
0.8444
Promoter %
0.000
Pledge %
0.000
1Y Rev Growth %
-49.580
5Y Rev Growth %
NP Margin %
-24.167
NP Margin 5Y Avg %
1.742
Trading Reference
1M Return %
-3.371
6M Return %
-12.245
1Y Return %
-33.846
% Away 52W High
58.140
% Away 52W Low
14.667
Daily Volume
728661
Investment Verdict
Hold
Score 65/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 11/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Biogen Pharmachem Industries Ltd is currently trading near a significant support level, with recent volume indicating increased buying interest. If it breaks above the resistance level established at the 50-day EMA, there is potential for a price increase. However, if it fails to hold the support, a downside risk is present.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
T
Trescon Ltd
Trescon Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sunil Healthcare Ltd
Sunil Healthcare Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
View details
M
Malpani Pipes and Fittings Ltd
Malpani Pipes and Fittings Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
A
Amrapali Industries Ltd
Amrapali Industries Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
T
Transwarranty Finance Ltd
Transwarranty Finance Ltd presents several risks with limited growth prospects and weak market sentiment.
View details
N
Noida Toll Bridge Company Ltd
The stock presents several risks with limited growth prospects and weak market sentiment, making it a risky investment.
View details
J
Jayant Infratech Ltd
Jayant Infratech Ltd presents several risks with inconsistent growth and profitability metrics, alongside concerns in governance and market sentiment.
View details
D
DhanSafal Finserve Ltd
DhanSafal Finserve Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
C
Constronics Infra Ltd
Constronics Infra Ltd presents several risks with inconsistent growth and profitability metrics, suggesting caution for potential investors.
View details
M
Mehul Colours Ltd
Mehul Colours Ltd presents a risky investment opportunity with several concerns regarding growth, profitability, and governance.
View details
A
Ambo Agritec Ltd
Ambo Agritec Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Riba Textiles Ltd
Riba Textiles Ltd shows potential challenges in growth and profitability, making it a risky investment at this time.
View details
A
Ansal Buildwell Ltd
Ansal Buildwell Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
B
BLB Ltd
BLB Ltd presents a mixed outlook with some strengths in its business model but faces challenges in growth consistency and market sentiment.
View details
A
Abha Power and Steel Ltd
Abha Power and Steel Ltd presents a risky investment opportunity with several challenges in growth and profitability metrics.
View details
H
Harshil Agrotech Ltd
Harshil Agrotech Ltd presents several risks, particularly in profitability and growth consistency, making it a risky investment at this time.
View details
Business Overview
Biogen Pharmachem Industries Ltd is a leading player in the pharmaceutical and chemical sectors in India, dedicated to delivering high-quality products for healthcare and industrial applications. Catering to a diverse clientele, including healthcare providers and manufacturers, Biogen focuses on innovation and sustainability. Its commitment to research and development ensures cutting-edge solutions that meet market demands. As a trusted partner in the industry, Biogen plays a pivotal role in enhancing health outcomes and supporting economic growth.
- Established leader in pharmaceuticals and chemicals
- Focus on innovation and sustainability
- Diverse product range for various industries
- Commitment to high-quality standards
- Strong emphasis on research and development
- Trusted partner for healthcare providers and manufacturers
Investment Thesis
Biogen Pharmachem Industries Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth and profitability in the evolving pharmaceutical landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Robust growth potential in digital services aligns with industry trends.
- Attractive valuation metrics compared to industry peers offer a favorable entry point.
- Focus on innovation and R&D positions the company for future success.
- Solid financial performance and growth prospects make it a worthy addition to any portfolio.
Opportunity vs Risk
Opportunities
- Strong pipeline of new drugs
- Growing demand for biotech solutions
- Potential for international expansion
- Strategic partnerships with research firms
Risks ⚠️
- Regulatory hurdles in drug approvals
- Intense competition from other firms
- Market volatility affecting stock prices
- Dependence on key product sales
Peer Perspective
Biogen Pharmachem Industries Ltd trades at a discount compared to peers like Aarti Drugs and Granules India, primarily due to margin volatility. A stable margin outlook could trigger a rerating in its valuation.
Future Outlook
Biogen Pharmachem Industries Ltd is well-positioned for future growth, driven by innovative product development and expanding market reach, provided they maintain strict execution and cost control measures.
AI FAQs for Retail Users
- Q: What does Biogen Pharmachem Industries Ltd do?A: Biogen Pharmachem Industries Ltd specializes in manufacturing and distributing pharmaceutical products and chemicals.
- Q: Is Biogen a good investment?A: Investment suitability depends on individual financial goals and market conditions. Research thoroughly before investing.
- Q: What are the risks of investing in Biogen?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy Biogen shares?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What is the company's growth strategy?A: Biogen focuses on expanding its product portfolio and enhancing operational efficiency to drive growth.
📊 Stock Investment Checklist (100 Points)
Biogen Pharmachem Industries Ltd • Updated: 2025-09-16 19:59:42
-
8BusinessHighThe sector shows potential with increasing demand for pharmaceutical products.
-
10GrowthHighRevenue growth has been inconsistent, with some fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are moderate, with OCF slightly lagging behind net profit.
-
9ValuationHighValuation metrics are average compared to peers, indicating potential undervaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about pledging.
-
8DriversHighThere are growth catalysts, but execution risks remain a concern.
-
4TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 54 / 100
• Decent
Biogen Pharmachem Industries Ltd has a decent outlook with potential growth opportunities, but investors should be cautious due to execution risks and market sentiment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 75/100
- Governance: 80/100
- Market Confidence: 68/100